Assessing the effectiveness and safety of liposomal paclitaxel in combination with cisplatin as first-line chemotherapy for patients with advanced NSCLC with regional lymph-node metastasis: study protocol for a randomized controlled trial (PLC-GC trial)

BACKGROUND: Lung cancer is still the leading cause of cancer-related mortality worldwide. Around 80 to 85% of lung cancers are non-small cell lung cancer (NSCLC). Regional lymphatic metastasis is a frequent occurrence in NSCLC, and the extent of lymphatic dissemination significantly determines the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Luo, Liang, Gong, Yuliang, Wang, Bingjing, Zhu, Xiangdong, Zhou, Rufu, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599280/
https://www.ncbi.nlm.nih.gov/pubmed/23413951
http://dx.doi.org/10.1186/1745-6215-14-45

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599280/
https://www.ncbi.nlm.nih.gov/pubmed/23413951
http://dx.doi.org/10.1186/1745-6215-14-45

Ejemplares similares